Gastrointestinal case growth led the way for Surgery Partners (Nasdaq: SGRY) in the first quarter of 2025, contributing to strong surgical volumes and a solid start to the year. While a heavier GI mix placed modest pressure on average reimbursement rates, overall case growth remained strong, with orthopedic procedures and de novo expansion also fueling momentum across the platform, Surgery Partners CEO Eric Evans said during a May 12 earnings call. “GI case volumes are exceeding our long-term growth algorithm,” Evans said. “We really like our GI and ophthalmology business, and they continue to grow nicely.”
Read the full article: Surgery Partners Buoyed by Specialty Case Growth, Physician Recruitment and ASC Additions //
Source: https://ascnews.com/2025/05/surgery-partners-buoyed-by-specialty-case-growth-physician-recruitment-and-asc-additions